Latest revenue
$380.0K
as of 2026-03-31
Latest net income
$-2.8M
as of 2026-03-31
Net margin
-742.4%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $10.3M
- Enterprise value
- $10.3M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $6.78
- 52-wk low
- $1.99
- Beta
- —
- Shares out
- 4.3M
5-year trend
What this company does
BUSINESS Overview – SINTX Technologies SINTX Technologies is an advanced ceramics company formed in December 1996 that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. SINTX provides biomedical solutions for medical devices specializing in silicon nitride (Si₃N₄) for musculoskeletal and antipathogenic applications. We also manufacture parts made from silicon nitride for customers in the electrical, aerospace and other industrial sectors. SINTX is a global leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans…
AI summary unavailable — showing raw filing excerpt
Generated from SINT's filing dated 2026-03-20
Key risks
RISK FACTORS In addition to the other information contained in this Annual Report, the following risk factors should be considered carefully in evaluating our company. Our business, financial condition, liquidity or results of operations could be materially adversely affected by any of these risks. Risks Related to Our Capital Resources and Impairments We will require additional financing and our failure to obtain additional funding would force us to delay, reduce or eliminate our product development programs or commercialization efforts. We currently have limited committed sources of capital, and we have limited liquidity. Our cash and cash equivalents as of December 31, 2025 were $4.1…
AI summary unavailable — showing raw filing excerpt
Generated from SINT's filing dated 2026-03-20
Profitability
Gross margin
45.3%
37.0%Operating margin
-1053.1%
116.4%Net margin
-1018.1%
166.6%Return on equity
-353.8%
25.0%Return on assets
-109.0%
6.9%Leverage
Debt / equity
2.25×
58.4%Long-term debt / equity
0.06×
Debt / assets
69.2%
18.0%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $380.0K | +3.0% | $-2.8M | -23.1% | -742.4% |
Q4 2025 2025-12-31 | $290.0K | -46.5% | $-2.2M | -30.7% | -763.8% |
Q3 2025 2025-09-30 | $208.0K | -74.0% | $-3.5M | +43.3% | -1701.4% |
Q2 2025 2025-06-30 | $151.0K | -82.4% | $-2.3M | -5.2% | -1535.1% |
Q1 2025 2025-03-31 | $369.0K | -46.3% | $-2.3M | -158.7% | -621.1% |
Q4 2024 2024-12-31 | $542.0K | — | $-1.7M | — | -312.7% |
Q3 2024 2024-09-30 | $799.0K | +17.8% | $-6.2M | -95.6% | -780.9% |
Q2 2024 2024-06-30 | $859.0K | +69.1% | $-2.2M | +10.2% | -256.6% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Surgical & Medical Instruments & Apparatus · SIC 3841
Your notes
Keep private notes on SINT — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$547.2K
Insider selling
$0
Net activity
+$547.2K
Distinct insiders
5
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns SINT
Institutional value
$367.1K
Total shares held
147.2K
Distinct holders
11
-8 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | Veracity Capital LLC | 76.7K | $191.9K | +0 (+0.0%) | No change |
| 2 | VANGUARD FIDUCIARY TRUST CO | 23.5K | $58.1K | — | New |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 20.9K | $51.6K | — | New |
| 4 | Virtus Wealth Solutions LLC | 10.0K | $25.0K | +0 (+0.0%) | No change |
| 5 | Broadway Wealth Solutions, Inc. | 10.0K | $25.0K | +0 (+0.0%) | No change |
| 6 | UBS Group AG | 5.0K | $12.4K | -6.8K (-57.8%) | Trimmed |
| 7 | SIGNATUREFD, LLC | 1.1K | $2.9K | +0 (+0.0%) | No change |
| 8 | Farther Finance Advisors, LLC | 17 | $43 | +0 (+0.0%) | No change |
| 9 | SBI Securities Co., Ltd. | 14 | $35 | +0 (+0.0%) | No change |
| 10 | Cornerstone Planning Group LLC | 1 | $3 | +0 (+0.0%) | No change |
| 11 | CITIGROUP INC | 1 | $2 | +0 (+0.0%) | No change |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once SINT's latest filing finishes processing.